Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
11/2000
11/28/2000US6153812 Rapid and efficient regeneration of transgenic wheat plants
11/28/2000US6153811 Method for reduction of transgene copy number
11/28/2000US6153745 Relating to mutagenesis of nucleic acids
11/28/2000US6153744 Nucleoside derivatives with photolabile protective groups
11/28/2000US6153743 Lithographic mask design and synthesis of diverse probes on a substrate
11/28/2000US6153741 DNA methylation gene from plants
11/28/2000US6153740 Polynucleotide sequence coding a transport polypeptide; for the treatment of human tumors and viral diseases; antitumor agents
11/28/2000US6153739 Polynucleotides encoding human uridine diphosphate galactose-4-epimerase
11/28/2000US6153728 A protein encoded by an isolated nucleic acid molecule, the complementaray sequence of which hybridizes; producing a specific polyclonal antibodies
11/28/2000US6153600 Administering, in vivo, at or around the site of the solid tumor, a nucleic acid which encodes an ip-10 polypeptide, for inhibiting a solid tumor in a mammal
11/28/2000US6153599 Methoxyethoxy oligonucleotides for modulation of protein kinase C expression
11/28/2000US6153597 For gene therapy such as in vitro, ex vivo and/or in vivo transfer of genetic material
11/28/2000US6153596 Polycationic oligomers
11/28/2000US6153595 Composition and method for treatment of CMV infections
11/28/2000US6153593 Laminin 5 and the formation of basement membrane structure
11/28/2000US6153442 Compounds comprise two biotinyl radicals connected by a chain of atoms; the bis-biotin is conjugated to a member of a specific binding pair; for use in an assay for an analyte
11/28/2000US6153436 Transferring nucleotide sequences to target cells in vitro; for utilization as expression vectors for gene therapy
11/28/2000US6153435 Nucleotide sequences coding hybrid envelope polypetides; for gene therapy
11/28/2000US6153433 Suppressing microorganismal propagation; insertion of nucleotide sequences coding viricidal polypeptide into cells infected with hepatitis viral agent, monitor for propagation
11/28/2000US6153431 Human immunodeficiency virus co-receptor variants associated with resistance to virus infection
11/28/2000US6153430 Used as indicator of the presence of ovarian cancer tumor cells
11/28/2000US6153429 Cell lines useful for in vitro assay for indentification of carcinogens
11/28/2000US6153428 α(1,3) galactosyltransferase negative porcine cells
11/28/2000US6153427 Erythropoietin-inducible, erythroid-specific DNA construct
11/28/2000US6153425 Apparatus for the isolation and amplification nucleotide sequences; for the accurate and efficient detection of nucleotide sequences
11/28/2000US6153424 Cells with defective vacuole proteolytic enzymes; for the production of heterologous proteins
11/28/2000US6153423 Nucleotide sequence coding a heart polypeptide; for diagnosis, prevention, and treatment of heart, neuronal, immunological, and tumor defects; antitumor agents
11/28/2000US6153421 Nucleotide sequences which code microorganismal genome; for development of viricides; for preventing mammalian viral infection
11/28/2000US6153420 Protein with enzymatic activity; for the detection of modulators or enzymatic activity; for cleaving peptide linkage of substrate protein; for use as diagnostic tools in genetic engineering
11/28/2000US6153418 Enzymatic polypeptide for use in preparation of animal feeds
11/28/2000US6153417 CSAPK-1 protein and uses therefor
11/28/2000US6153410 Recombination of polynucleotide sequences using random or defined primers
11/28/2000US6153407 Erythropoietin DNA having modified 5' and 3' sequences and its use to prepare EPO therapeutics
11/28/2000US6153406 Transforming escherichia coli cells with vector coding for protein and selectable marker, culturing in media containing glucose and selection agent, protein is expressed and found in inclusion bodies
11/28/2000US6153405 Nucleic acid which encodes a leader sequence from nisin and/or subtilin and a lantibiotic; for recombinant production of antibiotics
11/28/2000US6153404 Regulatory sequence linked to sequence coding for a heterologous polypeptide; for controlled/inducible gene expression in recombinant system
11/28/2000US6153403 Lysosomal-associated multispanning membrane protein, LAPTM5 and nucleic acid encoding LAPTM5
11/28/2000US6153402 Death domain containing receptors
11/28/2000US6153401 Microorganisms and plasmids for 2,4-dichlorophenoxyacetic acid (2,4-D) monooxygenase formation and process for the production of these plasmids and strains
11/28/2000US6153398 Efficient method for drug screening by using recombinant auxotrophic strain that only expresses inosine 5'-monophosphate dehydrogenase from another species, applying compound to cells, and evaluating enzyme activity
11/28/2000US6153396 Drug screening by adding compound to mixture of chaperone and pilus subunit and determining the change in binding; bactericides for urinary tract infections
11/28/2000US6153395 ICAM-related protein
11/28/2000US6153391 Contacting p53 and oncoprotein with a peptide fragment or analogue including a defined amino acid sequence or an organic molecule having three-dimensional structure of that amino acid sequence; interferes with binding
11/28/2000US6153390 Isolated antigenic polypeptide from helicobacter pylori; for immunoassay diagnosis
11/28/2000US6153386 Analyzing the dna sequence of the angiotensinogen gene; mutation a-20c indicates a greater predisposition or a more severe hypertension
11/28/2000US6153385 Quantifying by isolating rna from cells, transcribing into cdna, amplifying cdna and competitor fragment using ligand-specific primers of defined nucleotide sequence, comparing amounts of ligand and competitor product
11/28/2000US6153383 Synthetic transcriptional modulators and uses thereof
11/28/2000US6153382 Viral growth inhibition
11/28/2000US6153380 In vitro mehtod by introducing library of random nucleic acids into cells to produce peptides, screening for cells exhibiting an altered phenotype; better intracellular localization of peptides
11/28/2000US6153378 Diagnosis of, and vaccination against, a positive stranded RNA virus using an isolated, unprocessed polypeptide encoded by a substantially complete genome of such virus
11/28/2000US6153377 Synthetic DNA derived recombinant HIV antigens
11/28/2000US6153201 Oral immunization with papillomavirus virus-like particles
11/28/2000US6153200 Administering an isolated and purified bacterial dnajp1 peptide having the amino acid sequence
11/28/2000US6153199 Avian recombinant live vaccine using, as vector, the avian infectious laryngotracheitis virus
11/28/2000US6153192 An amino acid sequence consisting of at least 6 contiguous amino acids and no more than 39 contiguous amino acids found at positions 144-183 of human microglobulin; for use in immunoassay to determine human microglobulin in a sample
11/28/2000US6153190 Monoclonal antibodies which are receptor agonists; use as the immunizing antigen
11/28/2000US6153189 Human TRK receptors and neurotrophic factor inhibitors
11/28/2000US6153187 Use of glycosaminoglycans degrading enzymes for management of airway associated diseases
11/28/2000US6153183 A modified human interleukin-3 polypeptide, comprises the replacement of 6 to about 44 residues at positions 17-118 of native interleukin-3 by other amino acids with the proviso that asparagine at position 101 and lysine at position 116
11/28/2000US6152358 Bioluminescent novelty items
11/28/2000CA2307470A1 Viral/insect gene that disrupts insect metamorphosis
11/28/2000CA2307357A1 Wbpp and method for assay of wbpp
11/28/2000CA2121659C Sample processing method for mycobacteria
11/28/2000CA2091243C Recombinant acc synthase
11/28/2000CA2074681C Genetic engineering process for the production of s-(+)-2,2-dimethylcyclopropanecarboxamide by microorganisms
11/28/2000CA2066428C Structural alterations of the egf receptor gene in human gliomas
11/28/2000CA2032253C 5-lipoxygenase activating protein
11/28/2000CA2016358C Method for the synthesis of ribonucleic acid (rna)
11/28/2000CA1341148C Methods and compositions for the preparation of treponema pallidum antigens, including purified antigens and dna sequences coding therefor
11/27/2000CA2309481A1 A process for the fermentative preparation of l-amino acids using coryneform bacteria
11/27/2000CA2307327A1 Process for the preparation of l-amino acids by fermentation and nucleotide sequences coding for the accda gene
11/23/2000WO2000070556A2 A method and relational database management system for storing, comparing, and displaying results produced by analyses of gene array data
11/23/2000WO2000070349A1 Identifying material from a breast duct
11/23/2000WO2000070342A2 Optical system analysis of cells
11/23/2000WO2000070341A2 Methods, pharmaceutical formulations and kits for identification of subjects at risk for cancer
11/23/2000WO2000070329A1 Nucleic acid-based detection
11/23/2000WO2000070100A1 Surface display of selenocysteine-containing peptides
11/23/2000WO2000070099A2 Differential gene expression in specific regions of the brain in neurodegenerative diseases
11/23/2000WO2000070098A1 Microarray-based subtractive hybridization
11/23/2000WO2000070097A2 Profile searching in nucleic acid sequences using the fast fourier transformation
11/23/2000WO2000070096A2 Methods of detecting colorectal disease by conduction an assay to detect a mutation in a bat-26 locus
11/23/2000WO2000070094A1 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
11/23/2000WO2000070092A1 Expression of ets-domain proteins in cancer
11/23/2000WO2000070091A1 ANTISENSE OLIGONUCLEOTIDE MODULATION OF HUMAN PROTEIN KINASE C-δ EXPRESSION
11/23/2000WO2000070090A1 Process for high throughput dna methylation analysis
11/23/2000WO2000070088A2 Immobilization of unmodified biopolymers to acyl fluoride activated substrates
11/23/2000WO2000070087A1 Automated nucleic acid compaction device
11/23/2000WO2000070086A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms
11/23/2000WO2000070076A1 Tm4sf receptors
11/23/2000WO2000070073A1 Method for sequencing nucleic acid molecules
11/23/2000WO2000070071A1 Adenovirus derived gene delivery vehicles comprising at least one element of adenovirus type 35
11/23/2000WO2000070070A1 Paramyxoviridae virus vector defective in envelope gene
11/23/2000WO2000070069A1 Acquired resistance genes in plants
11/23/2000WO2000070068A1 The maize rs81 promoter and methods for use thereof
11/23/2000WO2000070067A1 The rice actin 2 promoter and intron and methods for use thereof
11/23/2000WO2000070066A1 The maize rs324 promoter and methods for use thereof
11/23/2000WO2000070065A1 PROMOTER OF THIOREDOXINE TaTrxh2 IN WHEAT
11/23/2000WO2000070064A1 Polypeptides with protein disulfide reducing properties
11/23/2000WO2000070063A1 CONIOTHYRIUM MINITANS XYLANASE GENE $i(CXY1)
11/23/2000WO2000070062A1 Expression of sedoheptulose 1,7 bisphosphatase in transgenic plants
1 ... 3150 3151 3152 3153 3154 3155 3156 3157 3158 3159 3160 3161 3162 3163 3164 3165 3166 3167 3168 3169 3170 ... 4023